Effectiveness and cost effectiveness of pharmacological thromboprophylaxis for medical inpatients: decision analysis modelling study

MLA

Daniel Horner, et al. “Effectiveness and Cost Effectiveness of Pharmacological Thromboprophylaxis for Medical Inpatients: Decision Analysis Modelling Study.” BMJ Medicine, vol. 3, no. 1, Aug. 2024. EBSCOhost, https://doi.org/10.1136/bmjmed-2022-000408.

APA

Daniel Horner, Steve Goodacre, Kerstin de Wit, Beverley J Hunt, Abdullah Pandor, Sarah Davis, Mark Holland, & Xavier Luke Griffin. (2024). Effectiveness and cost effectiveness of pharmacological thromboprophylaxis for medical inpatients: decision analysis modelling study. BMJ Medicine, 3(1). https://doi.org/10.1136/bmjmed-2022-000408

Chicago

Daniel Horner, Steve Goodacre, Kerstin de Wit, Beverley J Hunt, Abdullah Pandor, Sarah Davis, Mark Holland, and Xavier Luke Griffin. 2024. “Effectiveness and Cost Effectiveness of Pharmacological Thromboprophylaxis for Medical Inpatients: Decision Analysis Modelling Study.” BMJ Medicine 3 (1). doi:10.1136/bmjmed-2022-000408.